Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoj S

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Nature|March 8, 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Nature Communications|July 4, 2023
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivoMoriya Tsuji, Manoj S Nair, Kazuya Masuda, et al.
Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Immunity|September 30, 2023
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational lockingLihong Liu, Ryan G Casner, Yicheng Guo, et al.
Cell Host & Microbe|March 31, 2021
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteGabriele Cerutti, Yicheng Guo, Tongqing Zhou, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational lockingLihong Liu, Ryan G Casner, Yicheng Guo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 25, 2025
A Human Immuno-Lung Organoid Model to Study Macrophage-Mediated Lung Cell Senescence Upon SARS-CoV-2 InfectionYuling Han, Dongliang Leng, Tuo Zhang, et al.
Aiche Journal. American Institute of Chemical Engineers|December 13, 2021
Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS-CoV-2Bharat Madan, Eswar R Reddem, Pengfei Wang, et al.
Nature|July 23, 2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeLihong Liu, Pengfei Wang, Manoj S Nair, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Nature|March 8, 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Nature Communications|July 4, 2023
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivoMoriya Tsuji, Manoj S Nair, Kazuya Masuda, et al.
Research Square|February 3, 2021
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody NeutralizationPengfei Wang, Lihong Liu, Sho Iketani, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7Pengfei Wang, Manoj S Nair, Lihong Liu, et al.
Immunity|September 30, 2023
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational lockingLihong Liu, Ryan G Casner, Yicheng Guo, et al.
Cell Host & Microbe|March 31, 2021
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersiteGabriele Cerutti, Yicheng Guo, Tongqing Zhou, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational lockingLihong Liu, Ryan G Casner, Yicheng Guo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 25, 2025
A Human Immuno-Lung Organoid Model to Study Macrophage-Mediated Lung Cell Senescence Upon SARS-CoV-2 InfectionYuling Han, Dongliang Leng, Tuo Zhang, et al.
Aiche Journal. American Institute of Chemical Engineers|December 13, 2021
Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS-CoV-2Bharat Madan, Eswar R Reddem, Pengfei Wang, et al.
Nature|July 23, 2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeLihong Liu, Pengfei Wang, Manoj S Nair, et al.
Pageof 14